Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases

Area of Science:

• Hematology
• Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stromal cells (MSCs) are crucial for cellular therapeutics.
• Limited data exists on bone marrow (BM)-derived MSCs from pediatric populations.
• Investigating pediatric BM MSC properties in hematologic diseases is essential.

Purpose of the Study:

• To characterize bone marrow (BM) mesenchymal stromal cells (MSCs) from children with hematologic disorders.
• To assess the functional capacity and differentiation potential of pediatric MSCs.
• To evaluate MSCs as a potential source for clinical applications.

Main Methods:

• Isolation and expansion of BM MSCs from children with non-malignant hematologic disorders and acute lymphoblastic leukemia (ALL).
• Immunophenotypic characterization, CFU-F assay, and cell doubling time calculation.
• Assessment of trilineage differentiation, apoptosis, and clonal analysis.

Main Results:

• MSCs acquired mesenchymal markers and lost hematopoietic markers post-isolation.
• Low apoptosis rates were observed across all passages.
• Comparable proliferative and clonogenic capacity, except for defective MSCs in ALL at diagnosis.
• Successful trilineage differentiation into adipocytes, osteoblasts, and chondrocytes.
• Clonal analysis revealed significant cellular heterogeneity within BM MSC populations.

Conclusions:

• Pediatric BM MSCs are viable for isolation in adequate numbers and quality for clinical use.
• MSCs from children with hematologic disorders, excluding ALL at diagnosis, show therapeutic potential.
• Further research is warranted to understand MSC behavior in ALL at diagnosis.